Critical Impurities in Pharmaceutical Water

Posted on

Image result for Pharmaceutical Water

The quality of the source water used to produce pharmaceutical water plays an important role for both the design of the treatment and the validation of the water system. FDA Warning Letters over the past few years have shown that compliance with the specification of pharmaceutical water is not enough. A validation of the treatment process is expected. This includes documentation of the process capacity to produce pharmaceutical water according to specification. If we do not know the quality of the source water, however, the purification capacity is not known either. As a consequence, fluctuations of the quality of the source (feed) water quality may lead to water that does not comply with the specification after purification. Or it is not known up to which quality level of the source water pharmaceutical water that complies with the specification can be produced. Therefore, it is important to know the impurities respectively their concentration in the source (feed) water.
The production of pharmaceutical water is always based on drinking water. The specifications for drinking water however (for Germany, stipulated in the Trinkwasserverordnung; for the U.S., in the National Primary Drinking Water Regulation) are defined very broadly compared to Pharmacopoeial specifications.

The quality of the drinking water varies widely as well, as drinking water may come from different sources (ground water or surface water). Even the ground water quality varies locally, e. g., depending on the season. This is why water purification plants for the pharmaceutical industry are not ready-made goods, but individual solutions that have to be developed by the future user and the plant supplier together. The plant supplier will always ask about the quality of the drinking water so that he can offer the appropriate processing technologies.

In particular, he will need the following information. For this purpose, it is useful to provide the plant engineer with various drinking water analyses over a minimum period of twelve months.

For the design of a pharmaceutical water plant, the indicator parameters according to the Trinkwasserverordnung (conductivity, iron, manganese, sulphate and pH value) are important, as the amount of the ionic load determines the treatment process. For instance, a single-stage or double-stage reverse osmosis may be sufficient to obtain adequate quality at low conductivity levels. Iron and manganese are limited by the drinking water ordinance, but will lead to irreversible membrane damage at the reverse osmosis plant when their limits (according to the Trinkwasserverordnung) are exceeded.

Image result for Pharmaceutical Water

Furthermore, information on the total hardness is indispensable, as it has a major influence on the design of the softening plant – as well as on carbonate hardness or base capacity which are used to calculate the amount of dissolved carbon dioxide. This parameter restricts the use of EDI or may require further treatment, such as membrane degassing.

Depending on the origin of the drinking water, a responsible plant engineer should measure the colloid index (SDI 15) before designing the plant. Especially with surface water, higher amounts are to be expected. A colloid index of more than 5%/min can already have a negative impact on the operation of a reverse osmosis plant (membrane blocking and/or fouling) and may require additional treatment techniques, such as ultrafiltration before the main plant. While the colloid index is never determined via the water supplier, the silicate content is often indicated in the drinking water analysis. A silicate content of more than 25 ppm can become critical for a combination of reverse osmosis and EDI and should also be determined in case it is not indicated in the analysis.

All microbiological parameters have been regulated in the Trinkwasserverordnung. However, you should always remember that the supplier guarantees the quality only up to the point of transfer. With regards to the total bacteria count in particular, regular tests are necessary in order to identify seasonal fluctuations.


Image result for Pharmaceutical Water

Image result for Pharmaceutical Water

////////////Critical Impurities, Pharmaceutical Water

Revision of the general Chapter on Pharmaceutical Water in the US Pharmacopoeia

Posted on

The 2nd supplement of USP39 NF34 comprises the revised version of the chapter on pharmaceutical water of the US Pharmacopoeia <1231> Water for pharmaceutical purposes.


The 2nd supplement of USP39 NF34 comprises the revised version of the chapter on pharmaceutical water of the US Pharmacopoeia <1231> Water for pharmaceutical purposes. The first draft version had already been published in September 2015 in the USP Pharmacopeial Forum 41(5).

First of all: there are no new or revised specifications of individual test parameters or new requirements. But the chapter has been revised structurally to ensure better readability. In addition there are now also details regarding feed water as well as for the validation and on action and warning limits. With a chapter number greater than 1000 the Chapter <1231> is not binding, but has a recommending character. The recommended temperature for hot sanitising was changed. So far temperatures of 80 ° C and greater were recommended. Now these are 65-80 ° C. Regarding the action and warning limits the USP now comprises proposals how these can be set 2 – and 3-stepped and which rationale can be used for the limit-setting. Further, the revised chapter now also provides assistance for organising sampling plans for the validation and operational phases.

The revised version of the Chapter <1231> will become effective in December 2016 and can be found in the 2nd supplement to the USP39 NF34.


EDQM adopts revised monograph for WFI allowing non-destillation techniques

Posted on Updated on


In a press release the EDQM has announced that the new monograph draft on Water for Injection (169) had been adopted. Read on to learn more about the production of WFI with membrane systems.



In a press release, the European Pharmacopeia Commission has announced that the revised monograph on Water for Injection (WFI) had been adopted.

According to the revised monograph, it will be allowed in Europe in future to produce WFI with a purification method equivalent to distillation like e.g. reverse osmosis coupled with appropriate techniques. Moreover, the EDQM declares that a notice to the respective supervisory authorities will be required when a “non-distillation” technology is used for the production of WFI. Besides, the EDQM points out that it is not only a matter of equivalence of a specification but rather the robustness of the purification of WFI. Therefore, Annex 1, which is currently under revision, will also include requirements with regard to the production of WFI. The new Annex 1 will be available when the revised monograph becomes applicable.

With the modification of this monograph, harmonisation with the US Pharmacopeia and the Japanese Pharmacopeia goes one step further. In both countries, non-distillation technologies for the production of WFI are already allowed.

The revised monograph Water for Injections (169) will be published in Ph.Eur. Supplement 9.1 and apply as of April 2017. For further information please see the EDQM’s press release.


//////production, WFI with membrane systems, EDQM, new monograph draft, Water for Injection (169)

Frequent Asked Question: Which Level of Ozone is Required in a Hot- or Cold-Stored WFI System?

Posted on


Ozone can be used for the sanitisation of water systems. Which level of concentration is required in water – i.e. in WFI – depends on different factors. Read more about the sanitisation of water systems with ozone.


The usage of ozone is only senseful in cold water systems. But the decisive question is whether ozone is used for a short-term (1-2 hours) or for a long term (> 6 hours) prevention of microbial growth. In the first case, > 50 ppb ozone is generally sufficient whereas in the second case at least 20 ppb are required.

One should keep in mind that WFI cold systems have basically a higher risk of microbial contamination. The need for ozone in large ring systems or in areas difficult to access may be higher. The ozone levels mentioned should thus be achieved in the return flow. Setting the correct ozone concentration for the system must be done within the scope of the PQ – i.e. validation of the water system.

In contrast, ozonisation of hot-stored WFI systems doesn’t make sense. Indeed, the half-life of ozone considerably decreases at temperatures over 40° Celsius. Moreover, the heat in hot WFI system causes sanitisation itself; the usage of additional ozone wouldn’t be meaningful. The risk of biofilm formation in hot-stored WFI systems is considerably lower.






Questions and Answers on the Topic “Pharmaceutical Water”

Posted on


In the following News, you will find questions on pharmaceutical water preparation and distribution frequently asked during our courses, as well as their respective answers. Read more here.


During our courses and conferences participants quite frequently raise questions on pharmaceutical water preparation and distribution. Therefore following you will find some of these questions and their respective answers.  

Question 1:  Which concentrations of ozone are required in water systems?

The technical literature delivers different information about the ozone concentrations in water systems: e.g. ISPE Baseline Water and Steam: 0.02 ppm – 0.2 ppm; Collentro, Pharmaceutical Water: 0.2 ppm – 0.5 ppm and W.Setz, Ciba-Geigy 1990: max 0.04 ppm, for sanitisation 0.05 ppm.
The indications provided by the ISPE Baseline refer to the concentration required to prevent microbial growth. One can thus assume that a concentration of 20 ppb ozone can prevent any growth.

If systemic protection is desired i.e. the constant presence of ozone in the water, lower ozone values are sufficient.
In practice, approx. 0.02 to 0.05 ppm should be sufficient for Aqua Purificata. For sanitisation, it naturally depends on the sanitation time intervals – daily or weekly. Finally, the required ozone concentration for the system should be determined within the framework of the validation for the whole system.

Question 2: How many ozone measurement points should be available in the water system?

If ozone is used for the sanitisation of the distribution system, the effect should also be proven by means of – indirectly – the determination of the KBE values on the one hand, and on the second hand through the proof that the ozone concentration is measured at the appropriate points in the water system. For this purpose, the ISPE Baseline mentions at least 3 measurement points:

  • In the storage tank
  • After the UV system
  • In the return flow

The measurement in the storage tank shows that the concentration is sufficient during the permanent ozonisation. After the UV system, a measurement is done to assure destruction of the ozone. The post-use point in the return flow of the pipeline system is measured to prove that the ozone concentration is sufficient during sanitisation.

Question 3: Is there – from a GMP point of view – a preferred sanitisation method?

Basically, the following three sanitisation procedures are used today:

  • Hot water sanitisation
  • Sanitisation with steam
  • Chemical sanitisation

The FDA, as well as the ISPE in its Baseline – are in favour of thermal sanitisation with steam. The Guidance for Industry: Sterile drug products produced by aseptic processing Prepared by Task Force (Japan) contains the following note:
Since water for injection needs to be microbiologically pure, the equipment used for its production should be capable of withstanding periodic sterilization with pure steam at temperatures over 121°C for a given length of time. If steam sterilization is not possible because of low heat tolerance, an alternative sterilization or sanitization procedure (e.g., hot water or chemical agents) should be used for the equipment.”
GMP doesn’t specify any method. According to the state of the art, one should prefer sanitisation with steam.

Question 4: Is cold storage allowed in WFI systems?

For WFI and purified water, different temperatures are used. WFI is usually stored under heat.
In FDA’s Guide to Inspections of High purity Water Systems you can find two indications of temperatures which are actually contradictory. The first temperature interval is described under “System Design”. “The fist chapter basically states under “System Design” that it is recognized that hot water systems (here to understand as 65 to 80°C systems) are self sanitizing. Another temperature interval is indicated in the chapter “Piping”. This concretely means here that the Guide applies to hot 75 – 80°C circulating systems. These indications are in connection with the 6D rule:
One common problem with piping is that of “dead-legs”. The proposed LVP Regulations defined dead-legs as not having an unused portion greater in length than six diameters of the unused pipe measured from the axis of the pipe in use. It should be pointed out that this was developed for hot 75 – 80°C circulating systems.”
It follows from the above that cold systems for WFI actually don’t comply with the requirements. Under these circumstances, it is likely that at least the FDA doesn’t accept cold WFI systems.

If appropriate measures (system design and sanitisation measures) can ensure that microbial growth is prevented, cold storage could basically be used. Different limits for cold storage can be found in guidelines and standards (Wallhäuser: 4°C;  ISPE: 4° to 10°C). A sanitisation concept for cold storage determined within validation is imperative and should also consider the increased high-risk of bio film formation.

Question 5: Are sterilizing filters permitted in water systems?

The answer to that question requires the examination of the legal provisions and the standards and guidelines on the topic “Water”. The EU GMP Guide describes in a few points the requirements for facilities and equipment. Relating to the sterilizing filters, the following indications may be authorised:

  • EU GMP 3.38: “Equipment should be installed in such a way as to prevent any risk of error or contamination.”
  • EU GMP 3.39: “Production equipment should not present any hazard to the products.”
  • EU GMP 3.36: “Manufacturing equipment should be designed so that it can be easily and thoroughly cleaned.”
  • EU GMP Annex 1: “Water treatment plants and distribution systems should be designed, constructed and maintained so as to ensure a reliable source of water of an appropriate quality.”

In almost all guidelines, references are made to sterilizing filters. As an example, see the following statement from a Japanese guideline: Sterile drug products produced by aseptic processing (Japan 2006)

“As a rule, sterilizing filters should not be placed at water use points since the filters could mask microbiological contamination in the water system. Endotoxins could also be released from dead microorganisms retained in the filters. If the use of filters is unavoidable, the interval of replacement should be based on validation results.”

In this Japanese document, the position to filters is obvious: no sterilizing filters should normally be used. Yet, there can definitely be exceptions. The filters shouldn’t serve for masking too high KBE values. Finally, one should justify the use of such a filter.

Microbiology test of water ( IP,BP,USP)

Posted on Updated on

Microbiology test of water ( IP,BP,USP)

Microbiological Test of Water is provided to determine compliance with the requirements given in individual monograph/specifications.
Microbial testing of water includes the estimation of the number of viable aerobic bacteria present in a given quality of water.
Phosphate Buffer pH 7.2
Stock Solution
Dissolve 34 g of monobasic Potassium phosphate in about 500 mL of water contained in a 1 L volumetric flask. Adjust to pH 7.2 ± 0.1 by the addition of 4 % w/v aqueous solution of Sodium hydroxide (about 175 mL), add water to volume, and mix. Dispense, sterilize and store under refrigeration.
For use, dilute the Stock solution with water in the ratio of 1 to 800, and sterilize in an autoclave at 121 OC for about 15 min.
Nutrient Agar Medium
Beef Extract 10.0 g
Peptone 10.0 g
Sodium Chloride 5.0 g
Agar 12.0 g
Water 1000 mL
Dissolve with the aid of heat. Adjust to pH 8.0 to 8.4 with 5 M Sodium Hydroxide and boil for 10 min. Filter , adjust to pH 7.2 to 7.4 and sterilise by maintaining at 115 OC for 30 min.Soyabean Casein Digest agar
Pancreatic Digest of Casein 17.0 g
Papacy Digest of Soybean Meal 3.0 g
Sodium Chloride 5.0 g
Dibasic Potassium Phosphate 2.5 g
Dextrose (C6H12O6. H2O) 2.5 g
Agar 12.0 g
Distilled Water 1000 mL
Final pH after Sterilization 7.3 ± 0.2
Dissolve the solids in the water, warming slightly to effect solution. Cool to room temperature and add, if necessary, sufficient 0.1 N Sodium Hydroxide to give a final pH after Sterilization between 7.1 and 7.5. Filter, if necessary, to clarify, distribute into suitable containers and sterilize in an autoclave at 121 OC for about 15min.
MacConkey’s broth
Peptone 20.0 g
sodium Chloride 5.0 g
Sodium Taurocholate 5.0 g
Lactose 10.0 g
Bromocresol purple 10.0 mg
Water 1000 mL
Dissolve the Peptone, the Sodium Chloride taurocholate in the water with the aid of heat. Adjust to pH 8.0 and boil for 20 min. Cool, filter and adjust to pH 7.4. Add the Lactose and the indicator solution, mix and distribute in tubes containing inverted Durham’s tubes. Sterilize by maintaining at 121 OC for 20 min
For double strength medium, use double the quantity of ingredients in the same amount of water.
All the above media should be incubated for 24 h at 37 OC before use. Any contaminated media should be discarded.
Instead of preparing media, use dehydrated media of Hi media can be used. Re hydrate the required quantity as per instructions on the bottle label, dispense in required quantities and sterilize at 15 psi at 121 OC for 20 min.
Perform the Total microbial Count as follows :
Assemble the membrane filtration unit by keeping 0.45 µm filter membrane of the holder of the unit and moisten the membrane with distilled water. Autoclave the entire unit at
121 OC for 15 min. and allow to cool. Transfer 100 mL of water sample to the unit and filter it under aseptic conditions, by applying vacuum.
Transfer the membrane intended for enumeration of total bacterial count onto the surface of nutrient agar OR Soyabean casein digest agar and incubate at 37 OC + 2 °C for 3 days. Repeat the filtration process with 100 mL sample. Observe the plates for development of colonies and report the results as Colony forming units (CFU) per 100 mL sample.
Perform the test for Total microbial count as follows :
1. Transfer aseptically 1 mL of the sample in each of two sterile Petri dishes.
2. Add to each dish approx. 20 mL of sterile nutrient agar / Soyabean casein digest agar previously cooled to about 45OC3. Cover the petridishes and mix the sample with the agar by rotating the dishes 3 times both in clockwise and anti-clockwise directions.
4. Allow the agar to solidify at room temperature.
5. Invert the petridishes and incubate them at 37 OC for 48 h.
6. After incubation, examine the plates for growth and count the number of colony forming units in each plate.
7. The average of both the readings is the total microbial count per mL.
Perform the Total microbial Count as follows .
1. Prepare 1/10 dilution of the water sample by transferring aseptically 10 mL of the sample to 90 mL sterile phosphate buffer pH 7.2
2. Transfer 1 mL from this to two sterile Petri dishes. Add sterile nutrient agar / Soyabean casein digest agar to them in the same manner as above and incubate at 37 OC for 3 days.
3. After incubation, note the number of colony forming units in each plate and calculate the average.
4. Multiply the average count by 10. The result is the Total microbial Count per ml
1. Perform the test for identification of Escherichia coli as per STP No. STP-046-00.
2. Perform the test for most probable number of coliforms as follows. Transfer aseptically 10 mL sample into each of five previously sterilized 10 mL double strength MacConkey’s broth tubes Similarly transfer 1 mL and 0.1 mL sample in 10 mL single strength MacConkey’s broth tube using 5 tubes for each sample quantity. Incubate all tubes at 37 OC for 48 h. and observe for gas production.
3 The number of positive findings of coliform group of organisms should be computed as the combination of positives and recorded in terms of most probable number (MPN) . The MPN for a variety of combinations isgiven in the Table I.
Keep adequate controls of Phosphate buffer pH 7.2, Nutrient agar and MacConkey Broth to confirm the validity of results.


Observe the sample by physical examination in a 100 ml Nessler’s cylinder. The sample shall be clear.
Check the odour of the sample. Report for any unusual odour.
Principle :
Color is determined by visual comparison of the sample with known concentrations of colored solutions.
Sampling :
Collect representative samples in clean glassware. Make the colour determination within a reasonable period because biological or physical changes occurring in storage may affect color. With naturally colored waters these, changes invariably lead to poor results.
Apparatus : Nessler tubes, matched, 50 mL, of tall form.
Preparation of Standards :
1. Dissolve 1.246 g of Potassium Chloroplatinate [K2PtCl2], [eq. of 500 mg metallic Pt.] and 1.00 g of crystallized cobaltous chloride [CoCl2 6H2O], [eq. to 250 mg of metallic Co] in distilled water with 100 mL conc. HCl and dilute to 1000 ml with distilled water.This stock standard has a colour of 500 units.
2. Prepare standards having colors of 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, and 70, by diluting 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 4.5, 5.0, 6.0, and 7.0 mL stock color standard with distilled water to 50 mL in Nessler Tubes.
Protect these colour standards against evaporation and contamination when not in use.
a. Estimation of Intact Sample
Observe sample color by filling a matched nessler’s tube to the 50 mL mark with sample and comparing it with standards. Look vertically downward through tubes toward a white or specular surface placed at such an angle that light is reflected upward through the columns of liquid. If the turbidity is present and has not been removed, report as ‘apparent color’. If the color exceeds 70 units, dilute sample with distilled water to known proportions until the color is within the range of the standards.
b. pH
Measure pH of each sample
Calculation (in case sample has been diluted)
Calculate color units by the following equations :
Color Units = [Estimated Color of diluted sample x 50 ] / mL sample taken for Dilution.
Report color results in whole numbers and record as follows :
Color Units Record to Nearest
0 – 50 1
51 – 100 5
101 – 250 10
251 – 500 20
Report the sample pH.
4. pH
Instrument : The pH meter should be capable of reading with an accuracy of 0.05 pH Units.
Calibration with Standard Buffer solutions : Before sample pH measurement perform calibration of the instrument with pH 4.0 buffer and pH 9.0/9.2 buffer.
Sample measurement : Establish equilibrium between electrodes and sample by stirring sample to ensure homogenity ; Stir gently to minimize carbondioxide entrainment. Measure the sample pH at 25C.
Report pH value to the nearest 0.1 pH unit.
Principle : Ethylenediaminetetracetic acid and its sodium salts [EDTA ] form a chelated soluble complex when added to a solution of certain metal cations. If a small amount of a dye such as Eriochrome BlackT or Calmaginte is added to an aqueous solution containing calcium and magnesium ions at a pH of 10.0 ± 0.1, the solution becomes wine red.
If EDTA is added as a titrant the calcium and magnesium will be complexed, and when all of the magnesium and calcium has been complexed the solution turns from wine red to blue, marking the end point of the titration. Magnesium ion must be present to yield a satisfactory end point.
Titration Precautions
Conduct titration’s at or near normal room temperature. The color change becomes impractically slow as the sample approaches freezing temperature. Indicator decomposition becomes a problem in hot water. Completion to the titration within 5 min. minimizes the tendency for CaCO3 , to precipitate.
Reagents :
Buffer Solution :
1. Dissolve 16.9 g Ammonium Chloride [(NH4Cl)], in 143 mL, conc. ammonium hydroxide [(NH4OH)]. Add 1.25 g magnesium salt of EDTA[commercially available ] and dilute to 250 mL with distilled water.
2. If the magnesium salt of EDTA is unavailable, dissolve 1.179 g disodium salt of ethylenediaminetetraacetic acid dihydrate (analytical reagent grade) and 780 mg magnesium sulfate [(MgSO4.7H2O)] or 644 mg magnesium chloride [(MgCL2.6H2O)] in 50 mL distilled water. Add this solution to 16.9 g NH4Cl and 143 mL of conc. NH4OH with mixing and dilute to 250 mL with distilled water. To attain the highest accuracy, adjust to exact equivalence through appropriate addition of a small amount of EDTA or MgSO4 or MgCl2.
Store Solution 1. and 2. in a plastic or borosilicate glass container for no longer than 1 month. Stopper tightly to prevent loss of ammonia [Nh3 ]
Eriochrome Black T. : Sodium salt of 1-(1-hydroxy-2-naphthylazo)-5-nitro-2-naphthol-4-sulfonic acid; No.203 in the Color Index. Dissolve 0.5 g dye in 100 g 2,2’,2”-nitrilotriethanol (also called triethanolamine) or 2-methoxymethanol (also
called ethylene glycol mono methyl ether). Add 2 drops per 50 mL solution to be titrated. Adjust volume if necessary.
Standard EDTA Titrant, 0.01M : Weigh 3.723 g analytical reagent – grade disodium ethylenediaminetetraacetate dihydrate also called (ethylenedinitrilo) tetraacetic acid disodium salt (EDTA) , dissolve in distilled water, and dilute to 1000 mL , standardize against Standard Calcium Solution as described in method given below.
Standard Calcium Solution : Weigh 1.000 g anhydrous CaCO3 powder [primary standard or special reagent low in heavy metals, alkalis, and magnesium] into a 500 mL erlemeyer flask. Place a funnel in the flask neck and add, a little a time, 1+1 HCl until all CaCO3 has dissoved. Add 200 mL distilled water and boil for few minutes to expel CO2 . Cool, add a few drops of methyl red indicator, and adjust to the intermediate orange color by adding 3N NH4OH or 1+1HCl, as required. Transfer by quantitatively and dilute to 1000 mL with distilled water: 1 mL = 1.00 mg CaCO3.
Titration of Sample
Select a sample volume that requires less than 15 mL EDTA titrant and complete titration within 5 minutes measured from time of buffer addition.
Dilute 25.0 sample to about 50 mL with distilled water in a porcelain casserole or other suitable vessel. Add 1 to 2 mL buffer solution. Usually 1 mL will be sufficient to give a pH of 10.0 to 10.1. The absence of a sharp end-point color change in the titration usually means that an inhibitor must be added at this point or that the indicator has deteriorated.
Add 1 to 2 drops indicator solution or an appropriate amount of dry-powder indicator formulation. Add Standard EDTA titrant slowly, with continuous stirring, until the last reddish tinge disappears. Add the last few drops at 3- to 5-s intervals.
At the end point the solution normally is blue. Daylight or a daylight fluorescent lamp is recommended highly because ordinary incandescent lights tend to product a reddish tinge in the blue at the end point.
Calculation :
Hardness (EDTA) as mg CaCO3 / L =
[mL titration for sample x mg CaCO3 , equivalent to 1.00 m L EDTA titrant]
mL sample.
In a neutral or slightly alkaline solution, potassium chromate can indicate the end point of the silver nitrate titration of chloride. Silver chloride is precipitated quantitatively before red silver chromate is formed.
Apparatus :
– Conical flask, 250 mL
– Burette, 50 mL.
Reagents :
Potassium Chromate Indicator Solution : Dissolve 50 g K2CrO4 in a little distilled water. Add AgNO3 solution until a definite red precipitate is formed. Let stand 12 h, filter, and dilute to 1 L with distilled water.
Standard Silver Nitrate Titrant, 0.0141 M (0.0141N): Dissolve 2.395 g AgNO3 in distilled water and dilute t 1000 mL. Standardize against NaCl by the procedure of “Titration” described below. 1.00 mL = 500 µg of Cl-.
Special Reagents for Removal of Interference :
Aluminium Hydroxide Suspension : Dissolve 125 g aluminium potassium sulfate or aluminum ammonium sulfate, AlK(SO4)2.2H2O or AlNH4(SO4)2.12H2O, in 1 L distilled water. Warm to 60o C and add 55 mL conc. ammonium hydroxide (NH4OH) slowly with stirring. Let stand about 1h, transfer to a large bottle, and wash precipitate by successive additions, with thorough mixing and decanting with distilled water, until free from chloride . When freshly prepared, the suspension occupies a volume of approximately 1L.
Phenolphthalein Indicator Solution
Sodium Hydroxide, NaOH, 1N :
Sulfuric acid, H2SO4, 1N
Hydrogen Peroxide, H2O2, 30% :
Method :
Sample Preparation : Use a 100 ml sample or a suitable portion diluted to 100 mL. If the sample is highly colored, add 3 mL Al(OH)3 suspension, mix, let settle, and filter. If sulfide, sulfite, or thiosulfate is present, add 1 mL H2O2 and stir for 1 min.
Titration :Directly titrate samples in the pH range 7 to 10. Adjust sample pH to 10 with H2SO4 or NaOH if it is not in this range. For adjustment, preferably use a pH meter with a non-chloride-type reference electrode. (If only a clhloride-type electrode is available, determine amount of acid or alkali needed for adjustment discard this sample portion.
Treat a separate portion with required acid or alkali and continue analysis.) Add 1.0 mL indicator solution. Titrate with standard AgNO3 titrant to a pinkish yellow end point. Be consistent in end-point recognition.
Standardize AgNO3 titrant and establish reagent blank value by the titration method outlined above. A blank of 0.2 to 0.3 mL is usual.
Calculation :
mg Cl- / L =
(mL, titration for sample – mL titration for blank) x Normality of AgNO3 x 35.450
mL of sample
Principle :
A well-mixed sample is filtered through a standard glass fiber filter, and the filtrate is evaporated to dryness in a weighed dish and dried to constant weight at 105oC. The increase in dish weight represents the total dissolved solids.
Apparatus :
– Filtration apparatus : One of the following, suitable for the filter
disk selected.
– Membrane filter funnel.
– Gooch crucible, 25 mL to 40 mL capacity, with Gooch crucible
– Filtration apparatus with reservoir and coarse (40- to 60- µm)
– fritted disk as filter support.
– Suction flask, of sufficient capacity for sample size selected.
– Drying oven, for operation at 105 ± 2oC.
Method :
Preparation of glass-fiber filter disk : Insert disk with wrinkled side up into filtration apparatus. Apply vacuum and wash disk with three successive 20 mL
volumes of reagent-grade water. Continue suction to remove all traces of water. Discard washings.
Preparation of Evaporating Dish : If volatile solids are to be measured, ignite cleaned evaporating dish at 550o for 1 h. in a muffle furnace. If only total dissolved solids are to be measured, heat clean dish to 105 ± 2oC for 1 h in an oven . store in desiccator until needed. Weigh immediately before use.
Selection of Filter and Sample Sizes : Choose sample volume to yield between 10 and 200 mg dried residue. If more than 10 minutes are required to complete filtration, increase filter size or decrease sample volume. When very low total suspended solids are encountered (less than 10 mg/L), less dried residue may be collected; compensate by using a high-sensitivity balance (0.002 mg)
Sample Analysis :
Stir sample with a magnetic stirrer and pipette a measured volume onto a glass-fiber filter with applied vacuum. Wash with three successive 1 mL volumes of reagent-grade water, allowing complete drainage between washings, and continue suction for about 3 minutes after filtration is complete. Transfer total filtrate (with washings) to a weighed evaporating dish and evaporate to dryness on a steam bath or in a drying oven.
If necessary, add successive portions to the same dish after evaporation. Dry evaporated sample for at least 1 h. in an oven at 105 ± 2oC, cool in a desiccator to balance temperature, and weigh. Repeat drying cycle of drying, cooling, desiccating, and weighing until a constant weight is obtained or until weight change is less than 4% of previous weight or 0.5 mg, whichever is less. Duplicate determinations should agree within 5% of their average.
Calculation :
mg, total dissolved solids / L (ppm)=
{ [(Weight of dried residue + dish, mg) – Weight of dish, mg] x 1000 }
/sample volume mL
Determine total plate count and absence of pathogens as per the current version


1.0 AIM
To lay down a standard operating procedure for Decontamination of D.M. Water plant.
Maintenance Department
Service floor.
Operator/Maintenance Supervisor concerned.
Maintenance Incharge.
NOTE: Decontamination of D.M. Water plant is done as per recommendation of Q. C. department or once in a month; after regeneration of D.M. Water Plant.
6.1 Decontamination of Mixed Bed Unit
a) Mix 40 ml of formaldehyde solution with 200 ltr of D.M Water.
b) Inject this solution into mixed bed unit (MBU) by dipping tube attached to ejector E-2 into the formaldehyde solution and by opening valve 18, 20 & 22.
c) After completion of formalin injection close the valve 18, 20 & 22.
6.2 Decontamination of anionic exchanger
a) Mix 40 ml of formaldehyde solution with 200 ltr. D. M. Water.
b) Deep the tube attached to ejector into formaldehyde solution.
c) Open valve 4, 5, 6, 7 and adjsut valve 4 to maintain the flow.
d) After completion of injection close the valce 4, 5, 6 & 7
6.3 Decontamination of Cationic exchanger
a) Mix 40 ml of formaldehyde solution with 200 ltr. D.M. Water.
b) Deep the tube attached to ejector into formaldehyde solution.
c) Open valve 1, 2 & 3 and adjust the valve 2 to maintain the flow.
d) After completion of injection close the valce 1, 2, & 3.
6.4 Rinsing of columns
a) Next day start the D.M. Water plant (Ref. SOP-ME- ) and drain the water.
b) Give the sample of D. M. Water to Q.C.
c) After getting OK from Q. C. collect the D. M. Water into D. M. Water collection tank.
After 2 years or when procedure is changed